Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02379390
Title Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enz (PRIMCAB)
Recruitment Terminated
Gender male
Phase Phase II
Variant Requirements No
Sponsors Sanofi
Indications
Therapies
Age Groups: adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Investigational Site Number 840030 Muscle Shoals Alabama 35661 United States Details
Investigational Site Number 840024 Anchorage Alaska 99508 United States Details
Investigational Site Number 840028 Anaheim California 92801 United States Details
Investigational Site Number 840004 Sacramento California 95817 United States Details
Investigational Site Number 840002 Boca Raton Florida 33486 United States Details
Investigational Site Number 840027 Lakeland Florida 33805 United States Details
Investigational Site Number 840006 Port Saint Lucie Florida 34952 United States Details
Investigational Site Number 840015 Ottawa Illinois 61350 United States Details
Investigational Site Number 840001 Covington Louisiana 70433 United States Details
Investigational Site Number 840017 Metairie Louisiana 70006 United States Details
Investigational Site Number 840012 Rockville Maryland 20850 United States Details
Investigational Site Number 840026 Omaha Nebraska 68198 United States Details
Investigational Site Number 840022 Canton Ohio 44718 United States Details
Investigational Site Number 840016 Myrtle Beach South Carolina 29572 United States Details
Investigational Site Number 124003 Edmonton T6G 1Z2 Canada Details
Investigational Site Number 124010 Greenfield Park J4V2H1 Canada Details
Investigational Site Number 124005 Hamilton L8V 5C2 Canada Details
Investigational Site Number 124004 London N6A 4L6 Canada Details
Investigational Site Number 124002 Montreal H2L 4M1 Canada Details
Investigational Site Number 124006 Montreal H2W1S6 Canada Details
Investigational Site Number 124007 Ottawa K1H8L6 Canada Details
Investigational Site Number 124009 Quebec G1R 2J6 Canada Details
Investigational Site Number 124008 Saskatoon S7N4H4 Canada Details
Investigational Site Number 124001 Vancouver N5Z4E6 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field